Advanced Search

Study Preview



Study Title and Description

Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults. [1]



Key Questions Addressed
1 Is this an intervention study?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults. [1]
Author Morel FB., Dai Q., Ni J., Thomas D., Parnet P., Fan├ža-Berthon P.
Country
Year
Numbers

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Fiber 4.1
Arms
No arms have been defined in this extraction form.

Design Details
Question... Follow Up Answer Follow-up Answer
pubyear 2015
  • Comments Comments (
    0
    ) |
country China
  • Comments Comments (
    0
    ) |
design Randomized Controlled Trial (parallel)
  • Comments Comments (
    0
    ) |
blindness Double blind
  • Comments Comments (
    0
    ) |
diet Isocaloric/Maintenance
  • Comments Comments (
    0
    ) |
feedcontrol Food partially provided
  • Comments Comments (
    0
    ) |
sampsize 88
  • Comments Comments (
    0
    ) |
runin Unspecified
  • Comments Comments (
    0
    ) |
washout Not applicable
  • Comments Comments (
    0
    ) |
dosechange No
  • Comments Comments (
    0
    ) |
age_adult 1
  • Comments Comments (
    0
    ) |
age_adol 1
  • Comments Comments (
    0
    ) |
age_child
  • Comments Comments (
    0
    ) |
age_baby
  • Comments Comments (
    0
    ) |
age_infant
  • Comments Comments (
    0
    ) |
age_oth
  • Comments Comments (
    0
    ) |
age_mean ~31.25
  • Comments Comments (
    0
    ) |
age_range 18-45
  • Comments Comments (
    0
    ) |
bmi_mean 26.4
  • Comments Comments (
    0
    ) |
bmi_range 25-28
  • Comments Comments (
    0
    ) |
blhealth_healthy 1
  • Comments Comments (
    0
    ) |
blhealth_hyperlip
  • Comments Comments (
    0
    ) |
blhealth_diab
  • Comments Comments (
    0
    ) |
blhealth_hyperten
  • Comments Comments (
    0
    ) |
blhealth_digest
  • Comments Comments (
    0
    ) |
blhealth_met
  • Comments Comments (
    0
    ) |
blhealth_oth
  • Comments Comments (
    0
    ) |
blhealth_othspec
  • Comments Comments (
    0
    ) |
gender 50
  • Comments Comments (
    0
    ) |
ftype1 Galactooligosaccharide
  • Comments Comments (
    0
    ) |
descrip1_1 NA
  • Comments Comments (
    0
    ) |
descrip1_2 NA
  • Comments Comments (
    0
    ) |
dose1_1 6
  • Comments Comments (
    0
    ) |
dose1_2 NA
  • Comments Comments (
    0
    ) |
duration1 14 days
  • Comments Comments (
    0
    ) |
admin1 Beverage
  • Comments Comments (
    0
    ) |
ftype2 Galactooligosaccharide
  • Comments Comments (
    0
    ) |
descrip2_1 NA
  • Comments Comments (
    0
    ) |
descrip2_2 NA
  • Comments Comments (
    0
    ) |
dose2_1 12
  • Comments Comments (
    0
    ) |
dose2_2 NA
  • Comments Comments (
    0
    ) |
duration2 14 days
  • Comments Comments (
    0
    ) |
admin2 Beverage
  • Comments Comments (
    0
    ) |
ftype3 Galactooligosaccharide
  • Comments Comments (
    0
    ) |
descrip3_1 NA
  • Comments Comments (
    0
    ) |
descrip3_2 NA
  • Comments Comments (
    0
    ) |
dose3_1 18
  • Comments Comments (
    0
    ) |
dose3_2 NA
  • Comments Comments (
    0
    ) |
duration3 14 days
  • Comments Comments (
    0
    ) |
admin3 Beverage
  • Comments Comments (
    0
    ) |
ftype4
  • Comments Comments (
    0
    ) |
descrip4_1
  • Comments Comments (
    0
    ) |
descrip4_2
  • Comments Comments (
    0
    ) |
dose4_1
  • Comments Comments (
    0
    ) |
dose4_2
  • Comments Comments (
    0
    ) |
duration4
  • Comments Comments (
    0
    ) |
admin4
  • Comments Comments (
    0
    ) |
comparator1 Control
  • Comments Comments (
    0
    ) |
cdose1 0
  • Comments Comments (
    0
    ) |
cduration1 14 days
  • Comments Comments (
    0
    ) |
cadmin1 Beverage
  • Comments Comments (
    0
    ) |
comparator2
  • Comments Comments (
    0
    ) |
cdose2
  • Comments Comments (
    0
    ) |
cduration2
  • Comments Comments (
    0
    ) |
cadmin2
  • Comments Comments (
    0
    ) |
comparator3
  • Comments Comments (
    0
    ) |
cdose3
  • Comments Comments (
    0
    ) |
cduration3
  • Comments Comments (
    0
    ) |
cadmin3
  • Comments Comments (
    0
    ) |
comparator4
  • Comments Comments (
    0
    ) |
cdose4
  • Comments Comments (
    0
    ) |
cduration4
  • Comments Comments (
    0
    ) |
cadmin4
  • Comments Comments (
    0
    ) |


Baseline Characteristics
No baseline characteristics have been defined for this extraction form.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Comments

Quality Dimensions
No quality dimensions were specified.

Quality Rating
No quality rating data was found.